Search Results 1871-1880 of 13636 for monoclonal antibody

1. Relapsed or High-Risk Myeloma Receiving Novel Immunotherapies Outcomes of Patients - Mayo Clinic

   Participation eligibility · BCMA targeted cellular therapy including chimeric antigen receptor Tcells (CAR T-cells).; · BCMA targeted antibody-drug conjugate ...

2. A Study To Assess The Effectiveness And Safety Of Ublituximab In Combination With Umbralisib And Venetoclax (U2-V) Compared To Ublituximab And Umbralisib (U2) In Subjects With Chronic Lymphocytic Leukemia (CLL) - Mayo Clinic

   ... antibody) or chronic active Hepatitis C infection (HCV), cytomegalovirus (CMV), or known history of HIV. Subjects with positive HBc antibody or HCV antibody ...

3. A Study To Assess The Safety, Tolerability, And Pharmacokinetics Of BIIB078 In Adults With C9ORF72-Associated Amyotrophic Lateral Sclerosis - Mayo Clinic

   ... antibody immunoglobulin G, and positive HBcAb) or vaccination (defined as positive hepatitis B surface antibody) are eligible to participate in the study.

4. Lymphoma - Doctors and departments - Mayo Clinic

   nstrom macroglobulinemia, Monoclonal gammopathy of undetermined significance ... Bispecific antibody therapy · Bone marrow transplant · Cancer treatment ...

5. Multiple myeloma - Doctors and departments - Mayo Clinic

   Vincent Rajkumar, M.D.. Internist; Oncologist; Hematologist. Rochester, MN. Areas of focus: Amyloidosis, Multiple myeloma, Monoclonal gammopathy of undetermined ...

6. A Study Comparing BGB-3111 And Ibrutinib In Subjects With Waldenström's Macroglobulinemia (WM) - Mayo Clinic

   Participation eligibility · Presence of hepatitis B surface antigen (HBsAg) or anti-hepatitis B core antibody (anti-HBc). · Presence of hepatitis C virus (HCV) ...

7. A Study To Compare Venetoclax With Fulvestrant Vs. Fulvestrant Alone In Women With Locally Advanced Or Metastatic HER2-negative Cancer Who Have Progressed Or Recurred On A CDK4/6 Inhibitor - Mayo Clinic

   Positive test results for hepatitis B core antibody (HBcAb) or hepatitis C virus (HCV) antibody at screening: Patients who are positive for HCV antibody ...

8. Safety, Tolerability and Efficacy of AntiBKV as Treatment of BKV Infection in Kidney Transplant Recipients (SAFE KIDNEY II) - Mayo Clinic

   Recipients who, in the opinion of the investigator, are likely to require antibody-depletion therapy during trial participation. Antibody-depleting ...

9. Microscopic Polyangiitis Clinical Trials - Mayo Clinic Research

   ... antibody (ANCA)-associated vasculitis (AAV). PR3-AAV Resilient Remission or PRRR Rochester, MN. The purpose of this study is to determine the proportion of ...

10. Sharing Mayo Clinic: Second opinion shifts aspiring filmmaker’s outlook

    Neuromyelitis optica occurs when the body's immune system produces a molecule called an antibody that mistakenly targets healthy tissue. Antibodies normally ...